Indaptus Therapeutics

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell INDP and other ETFs, options, and stocks.

About INDP

Indaptus Therapeutics, Inc. is a pre-clinical biotechnology company. It engages in the development of a novel and patented systemically-administered anti-cancer and anti-viral immunotherapy. 

CEO
Jeffrey A. Meckler
CEOJeffrey A. Meckler
Employees
7
Employees7
Headquarters
New York, New York
HeadquartersNew York, New York
Founded
Founded
Employees
7
Employees7

INDP Key Statistics

Market cap
6.43M
Market cap6.43M
Price-Earnings ratio
-0.26
Price-Earnings ratio-0.26
Dividend yield
—
Dividend yield—
Average volume
36.10K
Average volume36.10K
High today
$0.4225
High today$0.4225
Low today
$0.40
Low today$0.40
Open price
$0.408
Open price$0.408
Volume
16.26K
Volume16.26K
52 Week high
$3.10
52 Week high$3.10
52 Week low
$0.40
52 Week low$0.40

People also own

Based on the portfolios of people who own INDP. This list is generated using Robinhood data, and it’s not a recommendation.
SNDL
Tilray Brands
Aurora Cannabis
Cenntro Inc.
NIO
Ocugen, Inc
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.